суббота, 30 июля 2011 г.

Leading European Contract Research Organization Selects OmniComm To Provide EClinical Solutions For Important Phase III Study

›
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, annou...
среда, 27 июля 2011 г.

Multiple Regulatory Cell Types Can't Keep Self-destructive Immune Cells Under Control

›
Multiple sclerosis (MS) is an autoimmune disease that occurs when cells of the immune system attack nerves in the brain. Although it is not ...
воскресенье, 24 июля 2011 г.

Researchers Say Hip Replacement Is Cost-Effective With No Age Limit For Benefits To Patients

›
Seniors with osteoarthritis who undergo total hip replacement are twice as likely as those who do not to show improvements in physical funct...
четверг, 21 июля 2011 г.

Rituximab Combined With A TNF Inhibitor And Methotrexate Shows No Safety Signal In RA Treatment

›
A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheum...
понедельник, 18 июля 2011 г.

Quigley Pharma Compound QR-443 Effective In Preventing Cachexia (Muscle Wasting)

›
Quigley Pharma, a wholly-owned subsidiary of The Quigley Corporation (Nasdaq: QGLY), announced today that it has obtained positive results f...
пятница, 15 июля 2011 г.

New Treatment Hope For Systemic Sclerosis

›
Systemic sclerosis (SSc) is a chronic autoimmune disorder marked by early skin lesions and the progressive tissue fibrosis. More than skin d...
вторник, 12 июля 2011 г.

Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients

›
In a two-year multicenter study led by University of Utah doctors, the dietary supplements glucosamine and chondroitin sulfate performed no ...